On September 25, 2019 X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, reported that the management team is scheduled to conduct one-on-one meetings at the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies, and to present and conduct one-on-one meetings at the 2019 Cantor Global Healthcare Conference (Press release, X4 Pharmaceuticals, SEP 25, 2019, View Source [SID1234539587]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details related to the team’s participation are as follows:

Conference:
Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies

Location:

New York, NY

Date:

September 23rd

Conference:

2019 Cantor Global Healthcare Conference

Location:

New York, NY

Presentation Date & Time:

October 2nd at 4:10 pm EDT